Pharmacoeconomics guidelines: The need of hour for India
Sukhvinder Singh Oberoi1★, Avneet Oberoi2★ Corresponding author
- 1Departments of Public Health Dentistry, Sudha College of Dental Sciences and Research, Faridabad, Haryana, INDIA.
- 2Oberoi Dental Clinic and Orthodontic Centre, Tagore Garden, New Delhi, INDIA.
CORRESPONDENCE
Sukhvinder Singh Oberoi
Departments of Public Health Dentistry, Sudha College of Dental Sciences and Research, Faridabad, Haryana, INDIA.
Volume 4, Issue 3 · pp. 109–111 · PUBLISHED · DOI: 10.4103/2230-973X.138338
ABSTRACT
Although the government pays for approximately 20% of drugs used in India, private out-of-pocket expenditure in India on health-care is one of the highest in the world. Preparing pharmacoeconomics guidelines will be an important step in order to establish Health Technology Assessment (HTA) in India. Areas in which HTA could be applied in the Indian context include, drug pricing, development of clinical practice guidelines and prioritizing interventions that represent the greatest value within a limited budget. All this calls for action, both by government and civil-society organizations, to make access to essential medicines a priority.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Oberoi, S. S., & Oberoi, A. (). Pharmacoeconomics guidelines: The need of hour for India. International Journal of Pharmaceutical Investigation, 4(3), 109–111. https://doi.org/10.4103/2230-973X.138338